Skip to main content
padlock icon - secure page this page is secure

Open Access Characterising Cancer Signalling Networks to improve treatment of poor prognosis human malignancies

Download Article:
(PDF 350.6 kb)
Perturbations in cellular signalling play a fundamental role in human cancer and provide the rationale for many targeted therapies. Recent advances in mass spectrometry (MS)-based proteomics allow global 'snapshots' to be taken of specific post-translational modifications, including protein phosphorylation, and thus provide systems-level insights into cellular signalling networks. Recognizing the potential of these approaches, Professor Daly's group has established cutting-edge technology platforms in MS-based phosphoproteomics and kinomics. The Signalling Network Laboratory's vision is to exploit these technologies to identify novel therapeutic targets and biomarkers for particular poor prognosis human cancers, including basal breast cancer and pancreatic cancer, through an integrated strategy that combines phosphoproteomic profiling of cancer subtypes and global interrogation of the human kinome with bioinformatics and functional genomics. This work will inform and refine the subclassification of particular cancers, identify novel therapeutic targets as well as new applications for existing therapies, and identify companion biomarkers that help stratify patients for appropriate therapy. Ultimately this work will lead to improved treatments for cancer patients with resulting reductions in morbidity and mortality.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: October 1, 2017

More about this publication?
  • Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.

  • Subscribe to this Title
  • Terms & Conditions
  • Disseminating research in Impact
  • Information about Impact
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more